CANC ETF

$38.12

Fund Essentials - as of Dec 31, 2025

Net Assets
$166M
Expense Ratio
0.75%
Dividend Yield (Current)
0.05%
Holdings
57
Inception Date
Aug 15, 2023
Fund Family
Tema Global Limited
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+10.20%
1 Year+39.35%

Asset Allocation

Stocks: 98.87%
Cash: 1.13%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
RVMDRVMD7.27%
NOVN:SMNOVN:SM4.62%
LLYLLY4.52%
AZN:LNAZN:LN4.35%
BBIOBBIO4.25%
Top 10 Concentration: 43.38%Report Date: Dec 31, 2025
Download all 57 holdings for CANC
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.05%
Frequency
Annually
Latest Distribution
$0.02
Dec 10, 2025
12M Distributions
1 payment
Total: $0.02

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

CANC ETF Overview

CANC ETF (Tema Oncology ETF) is managed by Tema Global Limited with $165.8M in net assets. CANC expense ratio is 0.75%, holding 57 positions across sectors including Unknown. Inception date: 2023-08-15.

CANC performance shows a YTD return of 10.20%. The 1-year return is 39.35%. CANC dividend yield stands at 0.05%, paid annually.

CANC top holdings include RVMD (7.3%), NOVN:SM (4.6%), LLY (4.5%), AZN:LN (4.3%), BBIO (4.3%). View all CANC holdings, sector breakdown, or dividend history.

CANC can be compared against other funds using the overlap calculator or side-by-side comparison tool. CANC alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
-2.96%
YTD
+10.20%
1 Year
+39.35%
3 Year
N/A

Top 10 Holdings (43.4% of portfolio)

#TickerNameSectorWeight
1RVMDRVMDUnknown7.27%
2NOVN:SMNOVN:SMUnknown4.62%
3LLYLLYUnknown4.52%
4AZN:LNAZN:LNUnknown4.35%
5BBIOBBIOUnknown4.25%
6RO:FFRO:FFUnknown3.98%
7MRKMRKUnknown3.87%
8GMAB:COGMAB:COUnknown3.83%
9BMYBMYUnknown3.43%
10COGTCOGTUnknown3.26%